Results 41 to 50 of about 22,236,668 (323)

Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events [PDF]

open access: yes, 2012
An increase in serious adverse events with both regular formoterol and regular salmeterol in chronic asthma has been demonstrated in previous Cochrane reviews.ObjectivesWe set out to compare the risks of mortality and non-fatal serious adverse events in ...
Christopher J Cates   +3 more
core   +1 more source

Regular treatment with formoterol for chronic asthma: serious adverse events [PDF]

open access: yes, 2012
Epidemiological evidence has suggested a link between beta(2)-agonists and increases in asthma mortality. There has been much debate about possible causal links for this association, and whether regular (daily) long-acting beta2-agonists are safe ...
Christopher J Cates   +3 more
core   +1 more source

Thyroid immune-related adverse events following immune checkpoint inhibitor treatment.

open access: yesJournal of Clinical Endocrinology and Metabolism, 2021
BACKGROUND Thyroid dysfunction occurs commonly following immune checkpoint inhibition. The etiology of thyroid immune-related adverse events (irAEs) remains unclear and clinical presentation can be variable.
C. Muir   +7 more
semanticscholar   +1 more source

2 Immune related adverse events in endometrial cancer: a biomarker for treatment efficacy?

open access: yesGynecologic Oncology Reports, 2023
Objectives: Immunotherapy (IO), either as single agent or in combination (ex: pembrolizumab +/– lenvatinib), is a critical tool in the treatment of advanced/metastatic endometrial cancer (EC). In other tumor types, the incidence of immune related adverse
Vinita Popat   +2 more
doaj   +1 more source

Laboratory adverse events and discontinuation of therapy according to CD4+ cell count at the start of antiretroviral therapy. [PDF]

open access: yes, 2014
Few data describe antiretroviral treatment (ART)-related adverse events when treatment is initiated at CD4 cell counts more than 350 cells/μl.
Chadwick, D   +31 more
core   +1 more source

Adverse event data (TEAE = treatment related adverse events; SAE = serious adverse events; N = Number of patients; M = number of events).

open access: yes, 2022
Adverse event data (TEAE = treatment related adverse events; SAE = serious adverse events; N = Number of patients; M = number of events).
Lars Bruce (12634647)   +9 more
core   +1 more source

Harmonization of large-scale, heterogeneous individual participant adverse event data from randomized trials of statin therapy [PDF]

open access: yes, 2022
Background: Meta-analyses of individual-level data from randomized trials are often required to detect clinically worthwhile effects. The Cholesterol Treatment Trialists’ Collaboration, which includes data from numerous large long-term statin trials ...
Cholesterol Treatment Trialists’ Collaboration,   +2 more
core   +1 more source

Rheumatic Immune-related Adverse Events and Treatment of Immune Checkpoint Inhibitors

open access: yesZhongliu Fangzhi Yanjiu, 2020
Immune checkpoint inhibitors(ICIs) has revolutionized the treatment of cancer. However, with the rapid application of CPIs, the immune-related adverse events (irAE) have attracted more and more attention.
ZHANG Xue, LI Dake
doaj   +1 more source

Managing Treatment–Related Adverse Events Associated with Alk Inhibitors

open access: yesCurrent Oncology, 2014
Anaplastic lymphoma kinase (ALK) rearrangements have been identified as key oncogenic drivers in a small subset of non-small-cell lung cancers (xnsclcs). Small-molecule Alk kinase inhibitors such as crizotinib have transformed the natural history of nsclc for this subgroup of patients. Because of the prevalence of nsclc, ALK-positive patients represent
Rothenstein, J.M., Letarte, N.
openaire   +2 more sources

Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events [PDF]

open access: yes, 2010
Background An increase in serious adverse events with both regular formoterol and regular salmeterol in chronic asthma has been demonstrated in comparison with placebo in previous Cochrane reviews.
Christopher J Cates   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy